InvestorsHub Logo
Followers 13
Posts 1544
Boards Moderated 0
Alias Born 06/14/2018

Re: None

Saturday, 11/25/2023 4:28:35 PM

Saturday, November 25, 2023 4:28:35 PM

Post# of 34618
Phantom, I will start with a Thank You.
"We want to believe that Marker is the crème de la crème of cell therapy companies but the reality is they are just one of many and are still very small. They need to reach as many eyes as possible however possible and if they are paying for some of these appearances I would assume the cost to be negligible. As we all know the data will be the ultimate decider here. I was fortunate enough to be able to speak with Vera earlier this week and he seems very optimistic about the lymphoma data. I expect we have full data by the end of next year and if it can just mirror the BCM data I am confident none of these videos and "promo" pieces will be a concern to you any more."

OK, Thank You.
The reason all of these TPIV connections bothered me so much is because TPIV was dealing with lowlife Stratton Oakmont pumpers then (and management should have known better), and I just felt like, if we want to be a respectable biotech company, then act like it and do not associate yourself with pumps firms.

The reason I said that Caro was working for 2 years was from the quote:
"Not saying that you would f**k me or my family but to cut my portion of Marker in my opinion is wrong as I 100% brought this back to the table a year later."
So I read that, whatever Caro was doing, there were discussions concerning it a year previous to it actually starting.

I have no intention of ever selling unless we go over $50 (assuming we don't have another reverse split) as my stubborn mentality would rather lose it all then concede.

Thank You for your continued reasonable imput as you tend to calm me down a bit over these many years when I get worked up about something.


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News